$100M STRONG 🌟
We’ve hit a game-changing milestone: over $100 MILLION in funding for 🇨🇦 businesses!
A massive THANK YOU to our community of #EquiBackers. Together, we're rewriting the playbook and breaking barriers in 🇨🇦 entrepreneurship and private investing. #EquityForAll
Every strong pitch has one thing in common: disagreement. When teams rush into perfect alignment, tough questions often go unasked. Investors notice. Avoid groupthink to keep your pitch credible.
🎓 Pressure-test your pitch in our Learning Centre
If you like following the companies raising on Equivesto, our biweekly newsletter keeps it simple: who’s live, who’s gaining traction, and which milestones just dropped.
Get the next issue by signing up for our newsletter!
Founders set timelines.
The market sets reality.
Raising can take longer than planned, and that does not mean you are failing.
Here is today’s Raise Confession.
The founders who perform best on Equivesto aren’t the loudest... They’re the most prepared! If you’ve ever wondered what separates a good raise from a great one, here’s the pattern we see again and again.
Which one are you?
A McKinsey survey shows 79% of executives expect AI to reshape their work, yet only 10% have adopted it at scale. The gap isn’t interest—it’s missing processes, data standards, and internal alignment needed to deploy AI effectively.
Hard to hear, but not all shares give you a say. Many new investors assume every share has voting rights, but non-voting shares are common in private deals and can still offer economic upside without control.
Learn more on our website 🚀
Founder gear, but make it regulated ✨
If you haven’t checked out the Equivesto merch shop yet, this is your reminder. Grab your favourites and rep the ecosystem.
Founders don’t underestimate the work—they underestimate the time. The Planning Fallacy makes teams expect a 2-week launch when it’s really 3 months. Here’s why timelines slip and how to plan your raise with accuracy, not optimism.
Raising capital shouldn’t feel like guesswork. If you’re looking to raise $100K–$1.5M through a community-backed round, Equivesto helps founders unlock investment capital without the gatekeeping.
Start your raise today!
Great investors don’t choose between gut instinct and due diligence; they use both. Our Due Diligence for Angel Investors class breaks down the full process: phases, data rooms, NDAs, and what to verify vs. validate.
Cash flow issues drive 38% of startup shutdowns (@CBInsights). Often it’s not a lack of interest or traction, but spending that doesn’t match market reality. Strong financial management can be just as critical to survival as building the product.
Founders often confuse valuation with the amount they’re raising. When risk and reward don’t align, strong pitches turn into passes. Understanding the math and avoiding overconfidence can make or break an early round.
Pressure-test your valuation in our Learning Centre 💸
Teams run on communication, but the right rhythm isn’t universal. Deep-work hours protect focus, while regular touchpoints keep projects aligned. Both matter—it’s about balance.
Do you prefer uninterrupted focus or frequent check-ins during the day?
You worked hard on every slide. But investors are only human, and they skim.
Our Pitch Deck Review class helps you craft a deck that actually gets read.
Celebrating the founders building from every corner of the country and the investors backing them with capital, time, and belief.
Happy Canada Day from the Equivesto Team 🇨🇦
Due diligence exposes everyone’s true personality. Some investors open six spreadsheets… others just “feel it in their bones.”
Which one are you owning up to?
For decades, private investing was limited to the wealthiest 1% and closed networks. Equivesto was created to change that. As an Exempt Market Dealer, we give Canadians regulated access to early-stage private companies. Here’s what democratized investing really means.
📣 Campaign Milestone: MedReddie closed its raise on Equivesto with strong participation from accredited investors. Clear problem in fragmented medical supply chains, an AI-driven solution, and 100% paid pilots with hospital buyers.